Disease activity of geographic atrophy in fellow eyes of the pegcetacoplan phase III trials measured by automated AI-based OCT biomarker quantifications (GA) (ARVO 2023) - Apellis Medical Hub Canada

Disease activity of geographic atrophy in fellow eyes of the pegcetacoplan phase III trials measured by automated AI-based OCT biomarker quantifications

Share Via Email

Back to Conference Resources

GA Congress Presentations The Association for Research in Vision and Opthalmology (ARVO) 2023

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.